NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in NexImmune, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q2 2022
- Shares held
- 7.84M
- −462.6K (−5.6%) vs. Q2 2022
- Total value
- $4.34M
- −$9.02M (−67.5%) vs. Q2 2022
- New holders
- 6
- 6 more added
- Sold out
- 13
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $2.70K |
| Q2 2024 | 13 | $408.6K |
| Q1 2024 | 12 | $858.3K |
| Q4 2023 | 11 | $229.4K |
| Q3 2023 | 31 | $921.4K |
| Q2 2023 | 32 | $1.26M |
| Q1 2023 | 31 | $2.20M |
| Q4 2022 | 29 | $1.45M |
| Q3 2022 | 39 | $4.34M |
| Q2 2022 | 46 | $13.4M |
| Q1 2022 | 52 | $40.1M |
| Q4 2021 | 46 | $47.1M |
| Q3 2021 | 47 | $160.3M |
| Q2 2021 | 42 | $119.0M |
| Q1 2021 | 46 | $184.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding NexImmune, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 1 | $0 | 0.00% | −1,046−99.9% | Reduced |
| Wells Fargo & Company | 112 | $0 | 0.00% | +66+143.5% | Added |
| Royal Bank of Canada | 48 | $0 | 0.00% | +48 | New |
| Advisor Group Holdings, Inc. | 150 | $0 | 0.00% | +150 | New |
| BNP Paribas Arbitrage, SA | 1,349 | $748 | 0.00% | +1,349 | New |
| Morgan Stanley | 3,437 | $2.00K | 0.00% | −13,320−79.5% | Reduced |
| Smith, Salley & Associates | 11,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Davenport & Co LLC | 10,500 | $6.00K | 0.00% | +10,500 | New |
| Northern Trust Corp | 12,668 | $7.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 12,700 | $7.00K | 0.00% | +12,700 | New |
| Susquehanna International Group, LLP | 13,995 | $8.00K | 0.00% | −12,634−47.4% | Reduced |
| Qube Research & Technologies Ltd | 14,049 | $8.00K | 0.00% | −1,797−11.3% | Reduced |
| Tower Research Capital LLC (TRC) | 13,921 | $8.00K | 0.00% | +9,568+219.8% | Added |
| UBS Group AG | 14,624 | $8.00K | 0.00% | +12,075+473.7% | Added |
| Man Group plc | 20,336 | $11.0K | 0.00% | +20,336 | New |
| State Street Corp | 22,919 | $13.0K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 27,860 | $15.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 29,343 | $16.0K | 0.00% | −14,601−33.2% | Reduced |
| Raymond James & Associates | 30,622 | $17.0K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 38,746 | $21.0K | 0.00% | +12,125+45.5% | Added |
| Bridgeway Capital Management, LLC | 50,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| CAPROCK Group, Inc. | 56,582 | $31.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 62,956 | $34.0K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 66,214 | $36.0K | 0.00% | −25,000−27.4% | Reduced |
| 683 Capital Management, LLC | 100,687 | $56.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 111,882 | $62.0K | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 122,880 | $68.0K | 0.00% | 00.0% | Unchanged |
| M28 Capital Management LP | 133,442 | $74.0K | 0.08% | 00.0% | Unchanged |
| Millennium Management LLC | 161,429 | $90.0K | 0.00% | −19,879−11.0% | Reduced |
| Kettle Hill Capital Management, LLC | 370,691 | $206.0K | 0.05% | +98,244+36.1% | Added |
| EPIQ Capital Group, LLC | 390,600 | $217.0K | 0.11% | 00.0% | Unchanged |
| Bridger Management, LLC | 400,000 | $222.0K | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 473,977 | $263.0K | 0.00% | +27,057+6.1% | Added |
| FMR LLC | 525,000 | $291.0K | 0.00% | 00.0% | Unchanged |
| Allen Operations LLC | 635,934 | $353.0K | 0.09% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 801,371 | $444.0K | 0.00% | 00.0% | Unchanged |
| Slate Path Capital LP | 925,000 | $513.0K | 0.03% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 969,029 | $537.0K | 0.01% | −357,014−26.9% | Reduced |
| Artal Group S.A. | 1,200,000 | $666.0K | 0.03% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −86,200−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −42,321−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −29,084−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −20,285−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −10,253−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,173−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,414−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −669−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |